New Delhi: Drug major Lupin is eyeing acquisitions in various global markets, including the US, Latin America and Europe, as it looks to bolster its presence overseas. "When it comes to new markets, Lupin would go in for a deeper dive in the Latin American continent as well as Europe," Lupin Ltd CFO Ramesh Swaminathan […]
The post Lupin eyes global acquisition in to boost growth, market share appeared first on Firstpost.